| Q33562026 | Anticentromere antibody in patients without CREST and scleroderma: association with active digital vasculitis, rheumatic and connective tissue disease |
| Q54163851 | Antikinetochore and antitopoisomerase I antibodies in systemic scleroderma: comparative study using immunoblotted recombinant antigens, immunofluorescence, and double immunodiffusion. |
| Q80059890 | Autoantibody profile in systemic sclerosis as a marker for esophageal and other organ involvement in Turkish populations |
| Q53016035 | Clinical correlation of anticentromere antibodies. |
| Q27015533 | Immune Components of Liver Damage Associated with Connective Tissue Diseases |
| Q53653934 | Incidence and clinical correlation of anticentromere antibody in Thai patients. |
| Q35040109 | Liver abnormalities in rheumatic diseases |
| Q36682146 | Lung function abnormalities and decline of spirometry in scleroderma: an overrated danger? |
| Q36722268 | The diagnosis and classification of scleroderma (systemic sclerosis) |
| Q38622370 | The management of autoimmunity in patients with cholestatic liver diseases |
| Q53509114 | [Gastrointestinal involvement in systemic sclerosis]. |